UG

MKT CAP:$33M

United-Guardian, Inc.

Market Cap

$33M

Consumer Defensive·Household & Personal Products·🇺🇸 United States·NASDAQ

Consumer Def.·Household·🇺🇸·NASDAQ

Stock Price

$7.21+$1.08 (+17.62%)

Apr 24, 2026

Company Details

United-Guardian, Inc. manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and proprietary specialty industrial products in the United States and internationally. The company offers cosmetic ingredients, inclu...

CEO

Donna Vigilante

IPO Date

Mar 17, 1980

Website

www.u-g.com

Key Metrics TTM

Revenue

$11M

-13.4% YoY

Net Income

$2M

EPS (Diluted)

$0.46

Free Cash Flow

$2M

Revenue / Share

$2.30

Gross Margin

47.7%

Operating Margin

21.3%

Net Margin

20.0%

FCF Margin

18.1%

P/S

3.1x

P/E

15.8x

Earnings Reports

Q1 2026

May 6, 2026

PENDING

FY 2025

Mar 27, 2026

$11M-13.4%EPS $0.46

Q4 2025

Mar 27, 2026

$3M+19.6%EPS $0.14

Q3 2025

Nov 6, 2025

$2M-26.0%EPS $0.06

Q2 2025

Aug 8, 2025

$3M-16.3%EPS $0.14

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q1 22	$4M	$2M	$2M
Q2 22	$4M	$2M	$1M
Q3 22	$2M	$1M	$687.7K
Q4 22	$3M	$1M	$645.7K
Q1 23	$3M	$1M	$831.8K
Q2 23	$3M	$1M	$518.1K
Q3 23	$3M	$1M	$721.9K
Q4 23	$3M	$1M	$791.3K
Q1 24	$3M	$2M	$1M
Q2 24	$3M	$2M	$1M
Q3 24	$3M	$2M	$949.1K
Q4 24	$2M	$1M	$556.4K
Q1 25	$2M	$1M	$610.9K
Q2 25	$3M	$1M	$695.5K
Q3 25	$2M	$925.8K	$215.1K
Q4 25	$3M	$1M	$721.9K

Valuation

Quarter	P/S	P/E
Q1 22	6.3x	20.7x
Q2 22	4.9x	19.1x
Q3 22	3.9x	17.5x
Q4 22	3.9x	19.1x
Q1 23	3.9x	18.2x
Q2 23	3.7x	17.1x
Q3 23	3.0x	13.3x
Q4 23	3.3x	14.0x
Q1 24	3.1x	13.1x
Q2 24	3.4x	12.9x
Q3 24	5.9x	20.9x
Q4 24	3.6x	13.5x
Q1 25	3.6x	14.3x
Q2 25	3.4x	14.4x
Q3 25	3.5x	17.9x
Q4 25	2.7x	13.3x

Operating Cash Flow

Quarter	Operating CF	Free CF
Q1 22	$27.4K	$22.6K
Q2 22	$1M	$1M
Q3 22	$735.9K	$688.0K
Q4 22	$624.7K	$609.7K
Q1 23	$417.6K	$415.0K
Q2 23	$434.7K	$433.3K
Q3 23	$1M	$1M
Q4 23	$1M	$1M
Q1 24	$644.1K	$622.2K
Q2 24	$1M	$1M
Q3 24	$1M	$1M
Q4 24	$269.3K	-$45.9K
Q1 25	$322.1K	$318.5K
Q2 25	$303.2K	$285.6K
Q3 25	$1M	$995.8K
Q4 25	$330.5K	$308.0K

Capital Expenditures

Quarter	CapEx
Q1 22	$4.8K
Q2 22	$7.5K
Q3 22	$47.9K
Q4 22	$15.0K
Q1 23	$2.6K
Q2 23	$1.3K
Q3 23	$68.4K
Q4 23	$93.4K
Q1 24	$22.0K
Q2 24	$65.3K
Q3 24	$30.6K
Q4 24	$315.2K
Q1 25	$3.6K
Q2 25	$17.6K
Q3 25	$15.2K
Q4 25	$22.5K

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q1 22	+13.5%	+25.3%
Q2 22	-0.9%	+13.2%
Q3 22	-24.0%	-9.5%
Q4 22	-24.5%	-8.1%
Q1 23	-34.0%	-27.2%
Q2 23	-26.9%	-12.1%
Q3 23	+26.5%	+35.1%
Q4 23	-5.6%	-14.2%
Q1 24	+26.6%	+28.2%
Q2 24	+27.9%	+6.7%
Q3 24	+0.1%	-9.6%
Q4 24	-5.0%	+5.8%
Q1 25	-23.8%	-16.1%
Q2 25	-16.3%	-5.8%
Q3 25	-26.0%	-2.9%
Q4 25	+19.6%	+16.6%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q1 22	$0	0.0%
Q2 22	$0	0.0%
Q3 22	$0	0.0%
Q4 22	$0	0.0%
Q1 23	$0	0.0%
Q2 23	$0	0.0%
Q3 23	$0	0.0%
Q4 23	$0	0.0%
Q1 24	$0	0.0%
Q2 24	$0	0.0%
Q3 24	$0	0.0%
Q4 24	$0	0.0%
Q1 25	$0	0.0%
Q2 25	$0	0.0%
Q3 25	$0	0.0%
Q4 25	$0	0.0%

OpEx Breakdown

Quarter	R&D	SG&A
Q1 22	$131.7K	—
Q2 22	$112.3K	—
Q3 22	$120.9K	—
Q4 22	$125.9K	—
Q1 23	$127.0K	—
Q2 23	$128.7K	—
Q3 23	$98.1K	—
Q4 23	$110.2K	—
Q1 24	$103.0K	—
Q2 24	$111.7K	—
Q3 24	$111.1K	—
Q4 24	$131.1K	—
Q1 25	$114.4K	—
Q2 25	$107.9K	—
Q3 25	$117.1K	$620.9K
Q4 25	$124.3K	—

Revenue Segments

Quarter	Cosmetic Ingredients	Medical	Pharmaceuticals
Q2 25	$896.5K	$490.0K	$1M
Q3 25	$403.4K	$630.8K	$1M

Revenue by Geography

Quarter	Non-US	United States
Q2 25	$491.7K	$2M
Q3 25	$702.8K	$2M

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 22	$511.5K	$7M	$8M
Q2 22	$355.6K	$6M	$7M
Q3 22	$496.5K	$7M	$7M
Q4 22	$830.5K	$6M	$6M
Q1 23	$1M	$6M	$7M
Q2 23	$6M	$939.6K	$7M
Q3 23	$7M	$928.8K	$8M
Q4 23	$8M	$851.3K	$9M
Q1 24	$7M	$2M	$9M
Q2 24	$8M	$1M	$10M
Q3 24	$2M	$7M	$9M
Q4 24	$2M	$8M	$9M
Q1 25	$1M	$7M	$8M
Q2 25	$2M	$7M	$8M
Q3 25	$860.8K	$7M	$8M
Q4 25	$1M	$7M	$9M

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q1 22	5M	0.0%	0.0%
Q2 22	5M	0.0%	0.0%
Q3 22	5M	0.0%	0.0%
Q4 22	5M	0.0%	0.0%
Q1 23	5M	0.0%	0.0%
Q2 23	5M	0.0%	0.0%
Q3 23	5M	0.0%	0.0%
Q4 23	5M	0.0%	0.0%
Q1 24	5M	0.0%	0.0%
Q2 24	5M	0.0%	0.0%
Q3 24	5M	0.0%	0.0%
Q4 24	5M	0.0%	0.0%
Q1 25	5M	0.0%	0.0%
Q2 25	5M	0.0%	0.0%
Q3 25	5M	0.0%	0.0%
Q4 25	5M	0.0%	0.0%

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q1 22	$162.2K	24
Q2 22	$151.1K	24
Q3 22	$100.7K	24
Q4 22	$115.1K	24
Q1 23	$107.1K	24
Q2 23	$110.4K	24
Q3 23	$127.4K	24
Q4 23	$104.3K	25
Q1 24	$130.2K	25
Q2 24	$135.6K	25
Q3 24	$122.4K	25
Q4 24	$99.1K	25
Q1 25	$99.2K	25
Q2 25	$113.5K	25
Q3 25	$90.6K	25
Q4 25	$118.5K	25

Revenue / Employee